Novartis’ Strategic Overhaul
Pharma companies tighten their business focus.
As health care costs continue to rise and consumer demand for therapeutic proof of performance escalates, pharmaceutical companies like Novartis are conscientiously focused on strategically paring their portfolios, investments, customer segments, and lines of business to those that have higher payoffs.